According to Biotest 's latest financial reports the company's current EPS (TTM) is -$0.28. In 2022 the company made an earnings per share (EPS) of -$0.85 an increase over its 2021 EPS that were of -$1.86.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.28 | -67.18% |
2022 | -$0.85 | -54.27% |
2021 | -$1.86 | 99.36% |
2020 | -$0.93 | 471.15% |
2019 | -$0.16 | -103.03% |
2018 | $5.40 | -9663.05% |
2017 | -$0.05642 | -95.43% |
2016 | -$1.24 | -47.94% |
2015 | -$2.37 | -468.28% |
2014 | $0.64 | -42.66% |
2013 | $1.12 | -8.51% |
2012 | $1.23 | -31.45% |
2011 | $1.79 | 30.12% |
2010 | $1.38 | 36.09% |
2009 | $1.01 |